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Equine infectious anemia (EIA) is caused by a persistent lentivirus
infection. Infected horses are lifelong reservoirs for vector medi-
ated or iatrogenic transmission of EIA virus (EIAV). No vaccine is
currently available or likely to become so. Therefore control of
new cases depends upon the time honored strategy of serological
identiﬁcation of carriers and their disposition by quarantine and
or slaughter. In the United States EIA prevalence has declined
from 4% in 1972 when the control program began to its current
prevalence of approximately 0.001%. The agar gel immunodiffu-
sion (AGID) test has been the regulatory test since EIAV control
program began 43 years ago. This 4,000 fold reduction in preva-
lence underscores the effectiveness of the AGID test but it has a
couple of drawbacks: it requires 48 hours to read and is not as
sensitive as newer serological tests. Alert clinicians, regulators
and horse owners seek to implement and facilitate better man-
agement of outbreaks, pre purchase evaluations and import/
export requirements. To address the need for a faster and more
sensitive assay we carried out this study to compare a USDA-
licensed AGID test kit with a USDA-licensed modiﬁed indirect
ELISA (MI-ELISA) kit. The serum sample from an EIAV carrier
horse was serially diluted and used to determine the analytical
sensitivity of each assay: the MI-ELISA was 4-fold more sensitive.
A Center for Veterinary Biologics proﬁciency panel (validated by
AGID test) of 20 samples was tested: there was 100% concordance
between the two assays. Analytical time point samples from 6
experimentally infected horses were collect over a period 4
months (n¼100): analytical sensitivity of experimentally infected
horses was comparable for the two assays. The two assays were
used to test known weak positive samples collected from nine
carrier horses: the AGID test detected only two but the MI-ELISA
detected all nine (Table). Due to the speed (45 minutes) and
signiﬁcantly greater sensitivity of the MI-ELISA reﬂected in the
results of this study, screening of routine samples with it andSamples MI-ELISA AGID
test
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NA: not availableconﬁrmation of positives by the regulatory assay, AGID test,
would serve the needs of the equine industry for better and more
rapid risk management.
Comparison between the modiﬁed indirect enzyme-linked
immunosorbent assay (MI-ELISA) and agar gel immunodiffusion
(AGID) test in the sensitivity against the sera from weak EIA
positive carriers
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Equine infectious anaemia (EIA), equine viral arteritis (EVA) and
contagious equine metritis (CEM) are three major endemic equine
infectious diseases in France, although only a few cases have been
detected over the last ten years in the country. In view of the
serious economic impact of these diseases, three surveillance
systems have been implemented to monitor them. Each system is
dedicated to one disease and comprises various active and passive
surveillance components. The surveillance systems are imple-
mented separately even if they are based on similar components.
This lack of synergy may prevent optimal surveillance. Our
objective was to assess these surveillance systems and to compare
the results of the assessments in order to propose improvements,
including future synergies. We used the semi-quantitative OASIS
method1, already used to assess animal diseases and food safety
surveillance networks in different countries. We have identiﬁed
mutual strengths, including laboratories’ efﬁcacy, surveillance
tools and data collection. Contrarily, the current absence of central
institutional organizations, the poor data management and data
analysis were the main weaknesses of all systems (Figure 1).
Furthermore, the comparative assessment has highlighted manyFigure 1. Assessment of ten functional sections of the French EIA, EVA and
CEM surveillance systems using the OASIS method (the level of satisfaction
for each section is displayed as a percentage score).
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ciency of surveillance as awhole, including the implementation of
new joint tools or the pooling of existing teams, tools or skills,
especially in relation with information distribution, data man-
agement and outbreaks investigation. Assessing surveillance sys-
tems for animal diseases is necessary to ensure they meet their
objectives and provide high-quality health information. OASIS is a
standardized tool which facilitates comparison and readily high-
lights the individual strengths of each component as opportunities
that could be extended to other components. This research has
used the “OASIS Flash” method, which reduces the time required
for the collection of information about the surveillance systems’
operations and structure, compared with classical OASIS method.
Our study is an original application of OASIS because several sys-
temswere evaluated simultaneouslyand compared. This approach
requires minimal ﬁnancial resources and is not very time-
consuming. Such a comparative evaluation could conceivably be
applied to other surveillance systems, other industries and other
countries. This approach would be especially relevant to enhance
the efﬁciency of surveillance activities when resources are limited.
1 Hendrikx, P., Gay, E., Chazel, M., Moutou, F., Danan, C.,
Richomme, C., Boue, F., Souillard, R., Gauchard, F.,
Dufour, B., 2011. OASIS: an assessment tool of epide-
miological surveillance systems in animal health and
food safety. Epidemiol. Infect. 139, 1486-1496.044
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The Complement Fixation test (CFT) is the prescribed sero-diag-
nostic method for glanders for international trade. However, its
sensitivity and speciﬁcity has been questioned. False-negative
glanders test results may lead to the introduction of the infectious
agent into a glanders free-region and false-positive test results
may lead to unnecessary restrictions on international trade ofanimals and result in ﬁnancial losses for owners and the equine
industry. CFT alternative methods such as Western blot (WB) and
ELISAs have been developed but have not been fully validated to
date according to the principles and methods of validation of
diagnostic assays for infectious diseases. This project is funded by
OIE and aims the further development and ﬁnalization of vali-
dation of alternative methods like indirect ELISA including re-
combinant ELISA already developed in several laboratories
worldwide. The WB technique developed by the OIE-reference
laboratory, Germany, has given promising results during the last
years using the CFT and theWB in a two-cascade testing approach
[1, 2]. The iELISAs developed by the project partners EU Reference
Laboratory for Equine diseases, France and the Universidade
Federal Rural de Pernambuco, Departamento de Medicina Vet-
erinaria, Brazil using semi-puriﬁed B. mallei antigenic fractions as
well as the recombinant ELISA developed by the National
Research Centre on Equines, Hisar, India gave encouraging results
[3, 4].
The project is sub-divided into work packages (WP). WP1-
‘Constitution of a qualiﬁed sample collection’ of “true positive”
and “true negative”. Special attention will be given to the inclu-
sion of ﬁeld samples from endemic countries like Brazil, India and
Pakistan. WP2- ‘Producing standard sera for glanders’. Serum
from glandered animals identiﬁed in WP1 will be collected to
produce a large stock of positive sera as possibly international
standard for glanders serodiagnosis. These sera will be available
for thewhole community as standard control reagents and will be
included in the panel of sera for the validation pathway (WP3).
WP3- ‘Serological tests validation following OIE validation
pathway’. Performance of tests to be evaluated will be investi-
gated in parallel using sera collected in WP1. The validation will
include the analytical performance characteristics; repeatability,
analytical speciﬁcity including exclusivity and exclusivity. All tests
will be validated and compared regarding sensitivity using the
same panel of true positive samples. The test speciﬁcity is the
most discussed issue in glanders serological diagnosis. However,
the sample collection for the validation will include negative
samples from different regions. For example our partners from
Pakistan (University of Agriculture, Fasialabad) and Brazil
(Reference laboratory for Glanders, Recife) will contribute by
providing large sample collections.
Finally, for all tests the positive and negative predictive values
should be calculable based on actual prevalence situation in the
involved region, and allow to select the right test for the
respective situation, as there are eradication scenarios, surveil-
lance after being free of glanders, or for trade of animals. To
contribute to the availability of the tests upon validation, com-
panies will be encouraged to commercialize the ELISA and also
transform the technology into a faster ﬂow through assay (WP4).
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